Meeting on the Med 2021 | The potential of iPSCs in cell therapy

Jo Brewer, PhD, Adaptimmune, Philadelphia, PA, discusses the exciting potential of induced pluripotent stem cells (iPSCs) in cell therapy given their ability to give rise to any cell type in the body and high proliferative capacity. Compared to autologous stem cell-derived products, the use of allogeneic iPSCs offer the ability to develop large supplies of genetically modified cells for a wide range of applications in a large number of patients. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.